Study of a New Technique for Imaging Pancreatic Cancer
The purpose of this study is to see how well the experimental imaging agent 89Zr-DFO-HuMab-5B1 attaches to pancreatic tumors, and to find out whether PET/CT scans done with this imaging agent produce better images of cancer.
Pancreatic Cancer|Tumors That Express CA19-9
DRUG: MVT-2163|DRUG: MVT-5873
Number of subjects with treatment-related adverse events as assessed, assessed by CTCAE v4.0, 1 year|Biodistribution of MVT-2163, will be determined by measuring radiation exposure for key organs and tissues, 1 year
The purpose of this study is to see how well the experimental imaging agent 89Zr-DFO-HuMab-5B1 attaches to pancreatic tumors, and to find out whether PET/CT scans done with this imaging agent produce better images of cancer.